Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivativesYoshio Ogino, Norikazu Ohtake, Yoshikazu Nagae, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|February 2, 2013
Collagenous sprue diagnosed by double balloon endoscopyYu Yamamoto, Takeshi Yamada, Daisuke Akutsu, et al.
International Journal of Clinical Oncology|November 10, 2011
Can docetaxel therapy improve overall survival from primary therapy compared with androgen-deprivation therapy alone in Japanese patients with castration-resistant prostate cancer? A multi-institutional cooperative studyTomoyuki Shimabukuro, Shigeru Sakano, Kenji Matsuda, et al.
International Journal of Hematology|April 15, 2021
Pembrolizumab plus pomalidomide and dexamethasone for relapsed or refractory multiple myeloma (KEYNOTE-183): subgroup analysis in Japanese patientsMorio Matsumoto, Kenshi Suzuki, Junya Kuroda, et al.
International Journal of Surgery (London, England)|September 18, 2021
Prognostic impact of neoadjuvant chemotherapy in patients with synchronous colorectal liver metastasis: A propensity score matching comparative studyMasaki Ueno, Koji Komeda, Hisashi Kosaka, et al.
International Journal of Clinical Oncology|November 20, 2021
Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 studySatoshi Tamada, Chihiro Kondoh, Nobuaki Matsubara, et al.
Annals of Surgical Oncology|January 22, 2024
Double Negativity of MRI-Detected and Pathologically-Diagnosed Extramural Venous Invasion is a Favorable Prognostic Factor for Rectal CancerToshihiro Sakanaka, Hiromitsu Iwamoto, Kenji Matsuda, et al.
British Journal of Cancer|February 19, 2020
Anticancer effects of chemokine-directed antigen delivery to a cross-presenting dendritic cell subset with immune checkpoint blockadeYuki Mizumoto, Hiroaki Hemmi, Masahiro Katsuda, et al.
International Journal of Hematology|September 19, 2020
Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patientsNaoki Takezako, Hiroshi Kosugi, Morio Matsumoto, et al.
The Lancet Regional Health. Western Pacific|May 14, 2023
Optimal bowel resection margin in colon cancer surgery: prospective multicentre cohort study with lymph node and feeding artery mappingHideki Ueno, Kazuo Hase, Akio Shiomi, et al.
Pageof 22